Overview
The present invention relates to a novel formulation for Nonalcoholic steatohepatitis or NASH comprising a novel polysaccharide i.e. partially hydrolyzed tora gum (PHTG) which leads to enhanced absorption and sustained release of the drug Diadzein along with inulin. PHTG not only increases the drug absorption but also reduces scarring of the liver, thus preventing liver damage.